Skip to content
10-Q

Quarterly Report

BIOSPECIFICS TECHNOLOGIES CORP

0001558370-20-013305

← back to feed
Filed
Nov 9, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Nov 6, 2020 7.34M sh
Shares Diluted Q3 2020 · Sep 30, 2020 7.37M sh
Shares Diluted Q3 2020 · Sep 30, 2020 7.36M sh
Shares Diluted Q3 2020 · Sep 30, 2019 7.36M sh
Shares Diluted Q3 2020 · Sep 30, 2019 7.35M sh
Stock Repurchased Q3 2020 · Sep 30, 2020 $412.76K
Stock Repurchased Q3 2020 · Sep 30, 2019 $357.29K
Capex Q3 2020 · Sep 30, 2020 $69.47K
Operating Cash Flow Q3 2020 · Sep 30, 2020 $16.44M
Operating Cash Flow Q3 2020 · Sep 30, 2019 $14.54M
Short Term Investments Q3 2020 · Sep 30, 2020 $83.84M
Short Term Investments Q3 2020 · Dec 31, 2019 $84.24M
Cash And Equivalents Q3 2020 · Sep 30, 2020 $2.87M
Cash And Equivalents Q3 2020 · Dec 31, 2019 $5M
Stockholders Equity Q3 2020 · Sep 30, 2020 $135.31M
Stockholders Equity Q3 2020 · Jun 30, 2020 $129.42M
Stockholders Equity Q3 2020 · Dec 31, 2019 $124.49M
Stockholders Equity Q3 2020 · Sep 30, 2019 $117M
Stockholders Equity Q3 2020 · Jun 30, 2019 $110.31M
Stockholders Equity Q3 2020 · Dec 31, 2018 $97.59M
Current Liabilities Q3 2020 · Sep 30, 2020 $1.54M
Current Liabilities Q3 2020 · Dec 31, 2019 $1.42M
Total Liabilities Q3 2020 · Sep 30, 2020 $1.96M
Total Liabilities Q3 2020 · Dec 31, 2019 $2.16M
Current Assets Q3 2020 · Sep 30, 2020 $102.07M
Current Assets Q3 2020 · Dec 31, 2019 $109.27M
Total Assets Q3 2020 · Sep 30, 2020 $137.27M
Total Assets Q3 2020 · Dec 31, 2019 $126.65M
Eps Diluted Q3 2020 · Sep 30, 2020 $0.73
Eps Diluted Q3 2020 · Sep 30, 2020 $1.36
Eps Diluted Q3 2020 · Sep 30, 2019 $0.85
Eps Diluted Q3 2020 · Sep 30, 2019 $2.33
Eps Basic Q3 2020 · Sep 30, 2020 $0.73
Eps Basic Q3 2020 · Sep 30, 2020 $1.36
Eps Basic Q3 2020 · Sep 30, 2019 $0.86
Eps Basic Q3 2020 · Sep 30, 2019 $2.34
Sga Expense Q3 2020 · Sep 30, 2020 $3.06M
Sga Expense Q3 2020 · Sep 30, 2020 $10.23M
Sga Expense Q3 2020 · Sep 30, 2019 $1.98M
Sga Expense Q3 2020 · Sep 30, 2019 $6.61M
Rd Expense Q3 2020 · Sep 30, 2020 $179.45K
Rd Expense Q3 2020 · Sep 30, 2020 $461.88K
Rd Expense Q3 2020 · Sep 30, 2019 $143.19K
Rd Expense Q3 2020 · Sep 30, 2019 $454.04K
Net Income Q3 2020 · Sep 30, 2020 $5.39M
Net Income Q3 2020 · Sep 30, 2020 $10M
Net Income Q3 2020 · Sep 30, 2019 $6.27M
Net Income Q3 2020 · Sep 30, 2019 $17.12M
Operating Income Q3 2020 · Sep 30, 2020 $6.51M
Operating Income Q3 2020 · Sep 30, 2020 $11.49M
Operating Income Q3 2020 · Sep 30, 2019 $7.32M
Operating Income Q3 2020 · Sep 30, 2019 $19.36M
Revenue Q3 2020 · Sep 30, 2020 $11.26M
Revenue Q3 2020 · Sep 30, 2020 $24.83M
Revenue Q3 2020 · Sep 30, 2019 $9.44M
Revenue Q3 2020 · Sep 30, 2019 $26.42M